SCIENCE INSIGHT by Boehringer Ingelheim
October 14, 2.30-3.00 pm
Speaker: Clemens Utschig, CTO Boehringer Ingelheim

This session will give a realistic, science driven look into the status quo of quantum computing and its potential applications within the pharma R&D value-chain. The talk will give insights into the challenges we are facing on the way to industrial advantage as well quantum’s link with AI and high performance computing. It will close with a call to action for academia as well as industry to unite towards making quantum a valuable technology for better medicines.